Non-invasive treatment of urinary symptoms and quality of life in women with Multiple Sclerosis

INTERVENTION: Randomized Blind Clinical Trial Study will be developed with 52 female patients aged between 18 and 59 years old, with a clinical diagnosis of Multiple Sclerosis (MS) who will be randomly distributed using opaque envelopes in two groups: experimental group and control group. The team will consist of 3 blind and independent investigators. The first will be responsible for screening and allocation to groups (randomization), the second researcher will perform EMG and pelvic evaluation and the third researcher will apply the treatment in both groups CONDITION: C10.114 Multiple Sclerosis PRIMARY OUTCOME: To evaluate the effects of transcutaneous tibial electrical stimulation on urinary symptoms and quality of life in women with Multiple Sclerosis. The Qualiveen ‐ Short Form (Q‐FS) and Overactivebladder (OAB‐V8) questionnaires will be used as an evaluation method SECONDARY OUTCOME: The experimental group is expected to have a greater impact on improving symptoms compared to the control group INCLUSION CRITERIA: Women; aged 18 to 59 years; with a clinical diagnosis of multiple sclerosis according to the Macnonald classification, of the relapsing type; who have symptoms of urinary disorders for at least si Xmonths; diagnosed with detrusor overactivity in the urodynamic test; if you cannot get a urodynamic test, the criterion will be at least three of the following symptoms: urgency, urge urinary incontinence, increased urinary frequency, nocturia and nocturnal enuresis